The bioburden testing market size is valued at USD 1.4 Bn in 2026 and is expected to reach USD 2.63 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.4% from 2026 to 2033. https://www.coherentmarketinsights.com/industry-reports/bioburden-testing-market